VAN ECK ASSOCIATES CORP – Takeda Pharmaceutical Company Limited Transaction History
VAN ECK ASSOCIATES CORP portfolio value:
$24.15M
portfolio value
VAN ECK ASSOCIATES CORP quarter portfolio value change:
-7.62%
quarter
Takeda Pharmaceutical Company Limited 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.42% | -127.75K shares | -3.78M | $12.97 | 1.86M |
| Q2 2022 | share | Increase | +76.51% | 862.50K shares | 11.79M | $14.04 | 1.98M |
| Q1 2022 | share | Decrease | -2.32% | -26.80K shares | 413K | $14.32 | 1.12M |
| Q4 2021 | share | Increase | +32.25% | 281.42K shares | 1.43M | $13.58 | 1.15M |
| Q3 2021 | share | Increase | +40.08% | 249.68K shares | 3.80M | $16.38 | 872.65K |
| Q2 2021 | share | Increase | +10.70% | 60.23K shares | 209K | $16.83 | 622.96K |
| Q1 2021 | share | Decrease | -7.26% | -44.04K shares | -767K | $18.26 | 562.73K |
| Q4 2020 | share | Increase | +3.07% | 18.08K shares | 541K | $17.81 | 606.77K |
| Q3 2020 | share | Increase | +4.96% | 27.83K shares | 446K | $17.45 | 588.69K |
| Q2 2020 | share | Increase | +14.90% | 72.74K shares | 2.64M | $17.54 | 560.85K |
| Q1 2020 | share | Increase | +10.16% | 44.99K shares | -1.33M | $14.85 | 488.11K |
| Q4 2019 | share | Increase | +18.81% | 70.14K shares | 2.32M | $18.8 | 443.11K |
| Q3 2019 | share | Decrease | -15.11% | -66.36K shares | -1.36M | $16.39 | 372.97K |
| Q2 2019 | share | Increase | +7.53% | 30.75K shares | -547K | $16.47 | 439.33K |
| Q1 2019 | share | Increase | 0.00% | 408.58K shares | 8.32M | $18.96 | 408.58K |